Polyoxidonium (azoximer bromide) - the Russian original drug produced by Petrovax-  was approved by the Ministry of Health of the Russian Federation for conducting an international clinical trial for the treatment of COVID-19.

Last year Petrovax, a pharmaceutical company, achieved great progress, demonstrating excellent performance and adopting a new development strategy.

PJSC MMC Norilsk Nickel, the world's largest producer of palladium and high-grade nickel and a major producer of platinum and copper, will be the first issuer of tokens in the project and the first industrial company to tokenize its assets on the platform.